Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs34914899 | chr16:1702103 | T/C | 4.68E-5 | 178 | 25.4 | 19.3 | 19.83 | KM Plot |
PCPG | rs34916810 | chr16:1764262 | GT/G | 7.13E-5 | 173 | 25.53 | 15.85 | 17.77 | KM Plot |
PCPG | rs34926712 | chr14:74512389 | T/A | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs34943350 | chr3:53012888 | C/T | 6.21E-6 | 178 | 25.17 | 26.57 | 11.78 | KM Plot |
PCPG | rs34950492 | chr16:1764899 | G/C | 6.54E-5 | 174 | 25.6 | 15.85 | 17.77 | KM Plot |
PCPG | rs34953016 | chr2:242540511 | T/C | 2.99E-5 | 176 | 25.87 | 27.27 | 20.28 | KM Plot |
PCPG | rs34959317 | chr14:39616211 | GTTTT/G | 8.96E-5 | 172 | 25.4 | 20.37 | 22.1 | KM Plot |
PCPG | rs34967203 | chr10:131550790 | CT/C | 7.31E-6 | 176 | 24.85 | 28.35 | 14.25 | KM Plot |
PCPG | rs34979715 | chr3:53048960 | G/A | 6.09E-6 | 177 | 25.17 | 26.92 | 11.78 | KM Plot |
PCPG | rs34983011 | chr2:242583952 | C/T | 8.88E-11 | 172 | 25.77 | 25 | 10.3 | KM Plot |
PCPG | rs34989058 | chr2:239074698 | C/T | 8.01E-5 | 174 | 29.43 | 18.2 | 13.22 | KM Plot |
PCPG | rs34993817 | chr16:1691361 | C/T | 0 | 178 | 25.4 | 22.77 | 2.93 | KM Plot |
PCPG | rs34996002 | chr14:74450405 | T/G | 3.7E-6 | 176 | 25.28 | 28.47 | 10.3 | KM Plot |
PCPG | rs35003429 | chr2:24313954 | TA/T | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs35008320 | chr3:39154864 | C/T | 8.94E-7 | 177 | 25.87 | 20.42 | 24.72 | KM Plot |